CGPCS
REGN icon

Capital Group Private Client Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Capital Group Private Client Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,017
Closed -$785K – 279
2025
Q4 		$785K Sell
1,017
-1,890
-65% -$1.28M 0.01% 216
2025
Q3 		$1.63M Sell
2,907
-19,965
-87% -$11.3M 0.03% 185
2025
Q2 		$12M Sell
22,872
-88,130
-79% -$49.2M 0.1% 133
2025
Q1 		$70.4M Buy
111,002
+19,672
+22% +$13.5M 0.69% 37
2024
Q4 		$65.1M Sell
91,330
-19,565
-18% -$16.4M 0.6% 44
2024
Q3 		$117M Buy
110,895
+10,667
+11% +$11.9M 1.11% 23
2024
Q2 		$105M Sell
100,228
-3,641
-4% -$3.53M 1.05% 22
2024
Q1 		$100M Buy
103,869
+10,857
+12% +$10.3M 1.02% 24
2023
Q4 		$81.7M Buy
93,012
+336
+0.4% +$277K 0.84% 32
2023
Q3 		$76.3M Buy
92,676
+26,108
+39% +$20.5M 0.93% 31
2023
Q2 		$47.8M Buy
66,568
+41,630
+167% +$32.1M 0.56% 63
2023
Q1 		$20.5M Buy
24,938
+2,048
+9% +$1.54M 0.25% 101
2022
Q4 		$16.5M Buy
22,890
+60
+0.3% +$44.3K 0.21% 114
2022
Q3 		$15.7M Buy
22,830
+82
+0.4% +$51.6K 0.22% 111
2022
Q2 		$13.4M Sell
22,748
-44
-0.2% -$28.6K 0.17% 120
2022
Q1 		$15.9M Buy
+22,792
New +$14.4M 0.17% 120

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Capital Group Private Client Services's REGN Position: Q1 2026 in Review

Capital Group Private Client Services sold out of Regeneron Pharmaceuticals (REGN) in Q1 2026, closing a stake of 1,017 shares — an estimated $785K sold.

Capital Group Private Client Services first reported a position in REGN in Q1 2022 and held it in 16 quarters. The position peaked at $117M in Q3 2024. 1,400 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Capital Group Private Client Services reported no remaining Regeneron Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Capital Group Private Client Services sold 1,017 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $785K.
  • Capital Group Private Client Services first reported a position in Regeneron Pharmaceuticals in Q1 2022 and held it in 16 quarters.
  • Capital Group Private Client Services's Regeneron Pharmaceuticals position peaked at $117M in Q3 2024.
  • 1,400 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Capital Group Private Client Services's 13F filing for Q1 2026, filed 13 May 2026.